Erik Emerson Abel PharmD, MBA
Critical Care Pharmacy, Pharmacotherapy
Vice President, Clinical Strategy & Innovation
Join to View Full Profile
127 Drake DrWexford, PA 15090
Erik Emerson Abel, MBA is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Erik Abel is a healthcare executive and pharmacist with 20+ years spanning payer, provider, MedTech, and digital health. He currently leads Clinical Strategy & Innovation at GE HealthCare’s Caption Care, where he scaled AI-guided cardiac ultrasound from 11 to 44 states, driving earlier disease detection, payer adoption, and value-based contracting.
Through his consultancy, OneAnother Health, Erik advises startups, investors, and professional organizations on commercialization and reimbursement strategies for AI SaMD, population health, and utilization management transformation. His earlier leadership roles at Highmark Health and The Ohio State University Wexner Medical Center advanced hospital-at-home, UM reform, CKD value-based care, and $50M in Medicaid-funded innovation programs.
He has authored 40+ peer-reviewed publications, delivered 30+ national talks, and is Epic® Physician Builder certified.
Education/Training: PharmD (WVU), MBA (OSU), BS Biology (Marshall), PGY-1 (OSUWMC), PGY-2 Cardiology (UPMC).
Education & Training
The Ohio State UniversityMBA, 2015 - 2017- West Virginia UniversityPharmD, 2002 - 2006
- Marshall UniversityBS, Biology , 1996 - 2000
Publications & Presentations
PubMed
- 1 citationsRisk Factors and Outcomes Associated with Prolonged Subtherapeutic Anticoagulation with Bivalirudin: A Retrospective Cohort Study.Libby A Orzel, Erik Abel, Danielle Blais, Tzu-Fei Wang, Kyle A Porter
Pharmacotherapy. 2019-12-01 - 15 citationsPerioperative use of blood products is associated with risk of morbidity and mortality after surgery.Eliza W. Beal, Fabio Bagante, Anghela Z. Paredes, Ozgur Akgul, Katiuscha Merath
American Journal of Surgery. 2019-07-01 - 2 citationsConsiderations for analgosedation and antithrombotic management during extracorporeal life supportPamela K Burcham, Alan Rozycki, Erik Abel
Annals of Translational Medicine. 2017-02-01
External Links
- LinkedInhttps://www.linkedin.com/in/erik-abel
- OneAnother Healthhttps://oneanother.health/
- Personal Sitehttps://erikabel.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
